Background Image
Table of Contents Table of Contents
Previous Page  30 / 62 Next Page
Information
Show Menu
Previous Page 30 / 62 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 31, No 1, January/February 2020

28

AFRICA

Results

The highest serum BNP (298.15

±

36.98 ng/l) and cTnI (180.32

±

19.69 pg/ml) levels were detected in the ES group. Significantly

lower levels were detected in the Sal intervention groups.

Compared with the control group, significantly higher

myocardial ROS levels were observed in the other groups (ES,

SLE and SHE) (

p

<

0.05,

n

=

6). Significantly lower ROS levels

were detected in the SLE (6.25

±

0.36 ng/mg) and SHE (4.91

±

0.74 ng/mg) groups than in the ES group (7.66

±

0.81 ng/mg,

p

<

0.01,

n

=

6). Significantly lower ROS levels were observed in

the SHE than the SLE group. Myocardial oxidative stress levels

were significantly increased by the acute exhaustion produced

by swimming, and myocardial ROS levels were reduced by Sal.

Myocardial CAT levels were significantly lower in the SLE,

SHE and ES groups than in the control group (0.60

±

0.04

ng/mg). Compared with the ES group, significantly higher

myocardial CAT levels were observed in the SLE and SHE

groups (

p

<

0.01,

n

=

6).

Significantly lower myocardial GSH levels were detected in

the ES, SLE and SHE groups than in the control group (3.30

±

0.45 U/mg). A significantly higher GSH level was observed in the

SHE than in the ES group (

p

<

0.05,

n

=

6) (Fig. 1).

Compared with the control group, the HR, Pes, dP/dt

max

and –dP/dt

min

were lower in the ES group, and the Ved, Ves, Ped,

EDPVR and Tau were all higher. The differences in SV, Ved, Ped

and Tau were significant between the Sal intervention groups

and the control group. The Pes, dP/dt

max

, –dP/dt

min

, Tau and

EDPVR were substantially higher in the SLE and SHE groups

than in the ES group. Compared with the control group, a lower

HR was recorded in the SLE and ES groups.

Non-significant differences in EF and ESPVR were observed

between the groups (

p

>

0.05,

n

=

6). Non-significant differences

in EF and ESPVR were also observed between the SLE and SHE

groups (Table 1).

HR was increased in the ES group (

p

<

0.05,

n

=

6). The PR

and QTc intervals were significantly longer in the ES, SLE and

SHE groups than in the control group. A larger R amplitude

was observed in the ES group (

p

<

0.01,

n

=

6), but a smaller

amplitude was observed in the SLE and SHE groups than in

the ES group (

p

<

0.01,

n

=

6). However the QT interval and P

amplitude were significantly higher in the ES and SLE groups.

The ST-segment of the ES group was changed (Table 2).

Compared with the control group (0.71

±

0.17), the change

in expression of Nrf2 mRNA was not statistically significant.

Compared with the ES group (0.57

±

0.13), a non-significant

change in expression of Nrf2 mRNA was observed in the SLE

(0.59

±

0.18) and SHE groups (0.54

±

0.06) after the application

of Sal. A non-significant change in expression of Keap1 mRNA

was observed (Fig. 2).

Compared with the control group (0.39

±

0.07), the level

of Nrf2 protein in the ES group (0.43

±

0.06) did not change

significantly. However, significantly higher levels of Nrf2 protein

were detected in the myocardium and nuclei of the SLE and SHE

groups (

p

<

0.01,

n

=

6). Compared with the SLE group (0.48

±

0

50

100

150

200

250

300

350

400

Con

ES

SLE

SHE

The l evel of BNP i n ser um

( ng/ L)

Serum BNP level (ng/ml)

**

**

#

##

**

Serum cTnI level (pg/ml)

0

50

100

150

200

250

Con

ES

SLE

SHE

The l evel of cTnI i n ser um

( pg/ mL)

**

**

**

#

#

0

1

2

3

4

5

6

7

8

9

Con

ES

SLE

SHE

The l evel of ROS i n myocar di um

( ng· mg- 1)

Myocardial ROS level (ng/mg)

##

##

++

**

**

**

0

0. 1

0. 2

0. 3

0. 4

0. 5

0. 6

0. 7

Con ES

SLE SHE

The l evel of CAT i n myocar di um

( ng· mg- 1)

Myocardial CAT level (ng/mg)

**

##

**

##

*

0

0. 5

1

1. 5

2

2. 5

3

3. 5

4

Con ES SLE SHE

The l evel of GSH i n myocar di um

( u· mg- 1)

Myocardial GSH level (U/mg)

**

**

#

**

Fig. 1.

The effect of Sal on serum BNP, cTnI and ROS levels, CAT and GSH in the myocardium after exhaustive exercise. The data

are presented as means

±

SD,

n

=

6 animals per group. BNP: brain natriuretic peptide; cTnI: cardiac troponin I; ROS: reactive

oxygen species; CAT: catalase; GSH: glutathione; Con: control group; ES: acute exhaustive swimming group; SLE: low-dose

salidroside plus exhaustive swimming group; SHE: high-dose salidroside plus exhaustive swimming group.

*

p

<

0.05 and

**

p

<

0.01 compared with the control group;

#

p

<

0.05 and

##

p

<

0.01 compared with the ES group;

++

p

<

0.01 compared with the

SLE group.